
1. Technology overview
contextflow GmbH is a radiology AI company founded in July 2016 as a spinoff of the Medical University of Vienna, located at Margaretenstrasse 70/2/8, 1050 Vienna, Austria. It supports radiologists in reading chest CT for lung cancer, interstitial lung disease and COPD.
ADVANCE Chest CT provides nodule detection, quantification and tracking over time, quantitative lung tissue analysis and qualitative analysis of 19 image patterns with reference cases. It runs inside the radiologist's existing viewer and PACS and can be combined with partner tools such as malignancy scoring. The CE-marked product is used by hospitals in Europe.
2. Highlighted features & specifications
- Nodule detection: finds and quantifies lung nodules on chest CT.
- Nodule tracking: compares nodules across follow-up scans in a timeline view.
- Lung tissue analysis: quantitative analysis for interstitial lung disease and COPD.
- Pattern library: qualitative analysis of 19 image patterns with reference cases and differential diagnoses.
- Viewer integration: runs inside the existing PACS viewer, with DICOM conformance documentation.
3. Potential application
Vietnamese hospitals can use nodule tracking in low-dose CT lung screening pilots. Pulmonology departments can quantify interstitial lung disease on follow-up scans. Radiology groups can offer second-read support for chest CT.
4. Benefits
Runs in the radiologist's native viewer, so no separate workstation is needed. Nodule tracking over time supports follow-up of screening patients. Partner malignancy scoring is cited in a clinical study as reducing false positive nodule detection by 18 percent. CE-marked software supports procurement in regulated markets.
5. Market trends & opportunities
National lung cancer screening programmes are expanding and create large volumes of chest CT that need nodule tracking support. Vietnam and Southeast Asia have high lung disease burden, so low-dose CT screening pilots could use such tools.
6. Other information
contextflow GmbH, Vienna, founded July 2016 as a spinoff of the Medical University of Vienna. Commercial partnerships: Curagita (2025-05) and Mint Medical for German lung screening workflows. 4DMedical is shown on the company site as acquirer (2026-06).
One platform connecting startups, corporations, research institutions, regions and investors











Playbook & Handbook · February 6, 2026
Winning Accelerator Playbook 2026 by BambuUP
RETAIL E-COMMERCE: AI AND REAL-TIME DATA ARE TRANSFORMING HOW RETAIL BUSINESSES OPERATE








































